Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.16%, EPS grew 133.3% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow GRDN
Guardian Pharmacy Services, Inc. (GRDN) P/E ratio
As of 16 October 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a P/E ratio of 37.5×. Over the past ten years it has ranged from 0.0× (September 2025) to 51.1× (June 2026); the current reading is higher than 29% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 38.1× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 39.9× | (10.00%) |
| Mar 2026 | 44.3× | 16.32% |
| Dec 2025 | 38.1× | (5.61%) |
| Sep 2025 | 40.4× | — |
| 7 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SGRY Surgery Partners, Inc. compare | n/m |
| ACHC Acadia Healthcare Company, Inc. compare | n/m |
| BKD Brookdale Senior Living Inc. compare | n/m |
| AVAH Aveanna Healthcare Holdings Inc. compare | 9.5× |
| MD Pediatrix Medical Group, Inc. compare | 13.1× |
| ADUS Addus HomeCare Corporation compare | 20.4× |
| ARDT Ardent Health, Inc. compare | 21.7× |
| GRDN Guardian Pharmacy Services, Inc. | 37.5× |
| ASTH Astrana Health, Inc. compare | 44.3× |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)